MDI and DPI Inhaler Formulations, Classifications, and Dosing Guidelines

Inhaled Corticosteroid (ICS) Monotherapy: Flovent / Fluticasone

  • Medication Identification and Classification:

    • Brand Name / Generic Formulation: Flovent / fluticasone (also referenced as florent/fluticasone).

    • Pharmacologic Class: Inhaled Corticosteroid (ICS).

    • Mechanism and Therapeutic Function: Exerts potent local anti-inflammatory activity within the respiratory tract, decreasing mucosal edema, cellular infiltration, and bronchial hyperreactivity in chronic pulmonary disorders such as asthma.

  • Formulations and Strength Dosages:

    • Metered-Dose Inhaler (MDI):

    • 44 mcg44\,\text{mcg} per actuation.

    • 110 mcg110\,\text{mcg} per actuation.

    • 220 mcg220\,\text{mcg} per actuation.

    • Dry Powder Inhaler (DPI):

    • 100 mcg100\,\text{mcg} per actuation.

Long-Acting Anticholinergic Monotherapy: Spiriva / Tiotropium

  • Medication Identification and Classification:

    • Brand Name / Generic Formulation: Spiriva / tiotropium (also referenced as tiotropium/totropium).

    • Pharmacologic Class: Long-acting anticholinergic (long acting anticholiner / Long-Acting Muscarinic Antagonist [LAMA]).

    • Mechanism and Therapeutic Function: Selectively inhibits muscarinic acetylcholine receptors (primarily M3M_3 receptors) in the bronchial smooth muscle, preventing acetylcholine-mediated bronchoconstriction and promoting persistent bronchodilation.

  • Formulations, Dosage Strengths, and Frequency:

    • Metered-Dose Inhaler (MDI):

    • 1.25 mcg1.25\,\text{mcg}

    • 2.5 mcg2.5\,\text{mcg}

    • Dosing Frequency: Administered 1x a day1\text{x a day} (once daily).

Inhaled Corticosteroid & Long-Acting Beta-Agonist (ICS / LABA) Combinations

  • Advair (Fluticasone & Salmeterol):

    • Drug Components:

    • Fluticasone: Inhaled Corticosteroid (ICS).

    • Salmeterol: Long-Acting Beta-Agonist (laba).

    • Therapeutic Synergy: Simultaneously addresses airway inflammation and delivers sustained bronchial smooth muscle relaxation via β2\beta_2-adrenergic stimulation.

    • Dry Powder Inhaler (DPI) Available Strengths:

    • 100/50 mcg100/50\,\text{mcg} (fluticasone 100 mcg100\,\text{mcg} / salmeterol 50 mcg50\,\text{mcg})

    • 250/50 mcg250/50\,\text{mcg} (fluticasone 250 mcg250\,\text{mcg} / salmeterol 50 mcg50\,\text{mcg})

    • 500/50 mcg500/50\,\text{mcg} (fluticasone 500 mcg500\,\text{mcg} / salmeterol 50 mcg50\,\text{mcg})

    • Metered-Dose Inhaler (MDI) Available Strengths:

    • 45/21 mcg45/21\,\text{mcg} (fluticasone 45 mcg45\,\text{mcg} / salmeterol 21 mcg21\,\text{mcg})

    • 115/21 mcg115/21\,\text{mcg} (fluticasone 115 mcg115\,\text{mcg} / salmeterol 21 mcg21\,\text{mcg})

    • 230/21 mcg230/21\,\text{mcg} (fluticasone 230 mcg230\,\text{mcg} / salmeterol 21 mcg21\,\text{mcg})

    • Dosing Frequency: Administered 2x a day2\text{x a day} (twice daily).

  • Breo Ellipta (Flovent & Vilanterol):

    • Drug Components:

    • Flovent (fluticasone furoate): Inhaled Corticosteroid (ICS).

    • Vilanterol: Long-Acting Beta-Agonist (laba).

    • Dry Powder Inhaler (DPI) Available Strengths:

    • 50/25 mcg50/25\,\text{mcg} (fluticasone 50 mcg50\,\text{mcg} / vilanterol 25 mcg25\,\text{mcg})

    • 100/25 mcg100/25\,\text{mcg} (fluticasone 100 mcg100\,\text{mcg} / vilanterol 25 mcg25\,\text{mcg})

    • 200/25 mcg200/25\,\text{mcg} (fluticasone 200 mcg200\,\text{mcg} / vilanterol 25 mcg25\,\text{mcg})

    • Dosing Frequency: Administered 1x a day1\text{x a day} (once daily).

  • Symbicort (Budesonide & Formoterol):

    • Drug Components:

    • Budesonide: Inhaled Corticosteroid (ICS).

    • Formoterol: Long-Acting Beta-Agonist (laba).

    • Metered-Dose Inhaler (MDI) Available Strengths:

    • 80/4.5 mcg80/4.5\,\text{mcg} (budesonide 80 mcg80\,\text{mcg} / formoterol 4.5 mcg4.5\,\text{mcg})

    • 160/4.5 mcg160/4.5\,\text{mcg} (budesonide 160 mcg160\,\text{mcg} / formoterol 4.5 mcg4.5\,\text{mcg})

    • Dosing Frequency: Administered 2x a day2\text{x a day} (twice daily).

Short-Acting Combination Bronchodilator Therapy: Combivent

  • Medication Identification and Classification:

    • Brand Name: Combivent.

    • Active Ingredients: Albuterol & Atrovent (ipratropium bromide).

    • Drug Classes:

    • Albuterol: Short-Acting Beta-Agonist (saba).

    • Atrovent: Anticholinergic [short] (Short-Acting Muscarinic Antagonist [SAMA]).

    • Therapeutic Synergy: Provides dual-pathway, rapid-onset acute bronchodilation by combining adrenergic stimulation with cholinergic antagonism.

  • Formulation, Delivery Dose, and Frequency:

    • Metered-Dose Inhaler (MDI) Strength: 100/20 mcg100/20\,\text{mcg} (albuterol 100 mcg100\,\text{mcg} / atrovent 20 mcg20\,\text{mcg}).

    • Dosing Frequency: Administered 4x a day4\text{x a day} (four times daily).

Device Classifications and Administration Summary

  • Metered-Dose Inhalers (MDI):

    • Mechanism: Pressurized aerosol canister delivering a precise microgram dosage per actuation.

    • Included Agents and Strengths:

    • Flovent / fluticasone: 44 mcg44\,\text{mcg}, 110 mcg110\,\text{mcg}, 220 mcg220\,\text{mcg}.

    • Spiriva / tiotropium: 1.25 mcg1.25\,\text{mcg}, 2.5 mcg2.5\,\text{mcg} (1x a day1\text{x a day}).

    • Advair (fluticasone/salmeterol): 45/21 mcg45/21\,\text{mcg}, 115/21 mcg115/21\,\text{mcg}, 230/21 mcg230/21\,\text{mcg} (2x a day2\text{x a day}).

    • Symbicort (budesonide/formoterol): 80/4.5 mcg80/4.5\,\text{mcg}, 160/4.5 mcg160/4.5\,\text{mcg} (2x a day2\text{x a day}).

    • Combivent (albuterol/atrovent): 100/20 mcg100/20\,\text{mcg} (4x a day4\text{x a day}).

  • Dry Powder Inhalers (DPI):

    • Mechanism: Breath-actuated micronized powder formulation.

    • Included Agents and Strengths:

    • Flovent / fluticasone: 100 mcg100\,\text{mcg}.

    • Advair (fluticasone/salmeterol): 100/50 mcg100/50\,\text{mcg}, 250/50 mcg250/50\,\text{mcg}, 500/50 mcg500/50\,\text{mcg} (2x a day2\text{x a day}).

    • Breo Ellipta (flovent/vilanterol): 50/25 mcg50/25\,\text{mcg}, 100/25 mcg100/25\,\text{mcg}, 200/25 mcg200/25\,\text{mcg} (1x a day1\text{x a day}).

  • Dosing Frequency Regimens:

    • Once Daily (1x a day1\text{x a day}): Spiriva (MDI), Breo Ellipta (DPI).

    • Twice Daily (2x a day2\text{x a day}): Advair (MDI & DPI), Symbicort (MDI).

    • Four Times Daily (4x a day4\text{x a day}): Combivent (MDI).